site:reference.medscape.com - Search Videos

Effective Strategies to Manage Obesity in the Primary Care Setting

Effective Strategies to Manage Obesity in the Primary Care Setting

Initiating Biologic Therapy for Atopic Dermatitis

Initiating Biologic Therapy for Atopic Dermatitis

Significance of Ejection Fraction in Chronic Heart Failure

Significance of Ejection Fraction in Chronic Heart Failure

Effective Use of Continuous Glucose Monitoring in Type 1 Diabetes

Effective Use of Continuous Glucose Monitoring in Type 1 Diab…

Managing Endocrine Therapy Resistance in Advanced/Metastatic HR /HER2- Breast Cancer

Managing Endocrine Therapy Resistance in Advanced/Metastati…

Managing Cardiovascular Risk in Patients With Chronic Kidney Disease

Managing Cardiovascular Risk in Patients With Chronic Kidney Dise…

IgA Nephropathy: Recognition and Management

IgA Nephropathy: Recognition and Management

Chronic Inflammatory Demyelinating Polyneuropathy

Multimechanism Heart Failure Treatment for Post- hospitalized H…

Improving Early Diagnosis in Alzheimer’s Disease

Combination Therapy for Low-Density Lipoprotein (LDL) Cholest…

Combination Therapy for Kidney Failure Risk in Type 2 Diabetes Pa…

Efficacy of Novel Weight Management Therapies

How CLL Treatment Is Evolving: Targeted Therapy, Sequencing, an…

Early Detection and Intervention of Chronic Kidney Disease in Type 2 …

Treatment Options for Advanced/Metastatic HR /HER2- B…

Improving Long-Term Outcomes in Early Breast Cancer

Heart Failure: Targeting the Mineralocorticoid Receptor for HF…

Diagnosis and Treatment of Alzheimer’s Disease in Patients Y…

Gaps in Treatment Guidelines for Atopic Dermatitis

Diagnosing and Treating Ankylosing Spondylitis

GLP-1 RA for Management of T2D and Heart Disease

Recurrence Reduction in High-Risk, Early HR /HER2- Breast Cancer

Update on CAR T-Cell Therapy in Multiple Myeloma

Chronic Kidney Disease in T2D: Early Diagnosis and Management

Graft vs Host Disease Highlights From EBMT 2023

Treatment Advances in HR /HER2- Metastatic Breast Cancer

Safety of JAK Inhibitors in Adults With Rheumatoid Arthritis

JAK Inhibitors in Moderate to Severe Rheumatoid Arthritis

Safety Considerations in the Treatment of Adult RA

See more videos